For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targeted mutations, Dr. Sands addresses how precision oncology is fundamentally changing lung cancer diagnosis and treatment.

The novel immunotherapy drugs, though proven to be safe and effective with significant improvements in response and survival rates, have challenges as well—this episode covers the gamut.

Episode Highlights

0:00 Start

1:00 Topic of discussion

2:42 Introducing Jacob Sands, MD

3:39 NCCN guidelines for lung cancer

6:51 Recently-approved drugs for lung cancer

13:46 Patient responses to targeted mutations

17:58 Off-target side effects with drugs

21:34 State of Lung Cancer report

23:04 Estimated number of candidates for targeted therapies

26:13 Insurance coverage for biomarker testing

28:12 Other issues with ordering biomarkers

31:20 Closing comments

32:36 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

In this episode, multiple points of view are presented regarding Asthma Exacerbated Respiratory Disease (AERD). Lungcast host Albert Rizzo, MD, was joined by allergist and immunologist Mitchell Grayson, MD, of Nationwide Children’s Hospital, as well as patient advocate Rhonda Nelson and her husband Wayne Nelson of The Little River Band. This discussion delves into the trials and tribulations of diagnosing—and living with—AERD, from disease misconceptions to daily management.

Join the discussion as these guests focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.

Episode Highlights
0:00 Start
1:00 Focus of each guest
2:55 Sampter’s triad and AERD
6:30 Patient experiences with AERD
10:18 Delayed diagnosis and recent changes
11:35 Therapy for AERD
16:32 Resources for patients with asthma
19:01 Day-to-day AERD management
24:14 Importance of keeping a medical journal
27:42 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

0:16 Intro
2:28 Recent modifications to the lung allocation score
5:11 Monitoring chronic graft rejection
9:23 The rising use of ex vivo lung perfusion 
16:17 The presence of post-COVID patients on the lung transplant waitlist
21:01 Impact of long Covid on transplant rehabilitation
22:51 Double lung transplant in bilateral lung cancer—what’s the future?
26:52 Effect of LAS on lung transplant survival racial disparity
31:05 What lies ahead in the practice of lung transplantation
35:00 Outro

Cleveland Clinic’s Maryam Valapour, MD, MPP, rejoins the broadcast, along with her colleague Kenneth McCurry, MD to discuss optimization of the lung allocation system to continue reducing waitlist times and patient mortality. 

It includes commentary on how recent changes to scoring protocols are expected to impact ongoing disparities related to race and socioeconomic status. They additionally talk about the role of transplantation in patients who have severely damaged lungs resulting from COVID-19 infection, an update since our April 2021 conversation.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode Highlights
0:15 Intro
3:09 Low-dose CT screening uptake in Canada
4:45 Evolution of adjuvant, neoadjuvant therapies
7:10 Reviewing CheckMate 816
10:56 Reviewing KEYNOTE-671
12:58 The impact of neoadjuvants on operability
16:15 Treatment-specific biomarkers for lung cancer
21:13 The short-term future of lung cancer therapy
24:31 Outro

Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network. 

It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode Highlights

0:15 Intro
1:48 Remembering the 1964 Surgeon General Report
3:01 The impact of the report on cardiology
6:47 The strategies and impact of anti-smoking campaigns
10:33 The modern vaping challenge
17:38 Outro

In recognition of 60 years since the 1964 Surgeon General Report—a historic contribution to our understanding of the negative health impacts of cigarette smoking—host Albert Rizzo, MD, meets with preventive cardiology expert Viet Le, DMSc, PA-C to reflect on the myriad of cascading effects delivered by this landmark report.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode Highlights
0:15 Introducing Sue Padernacht, EDd, PCC
1:16 The definition of burnout
3:53 The history of burnout
7:45 Differences between stress and burnout
14:34 Physical and behavioral signs of burnout
20:55 Steps the health care industry can take against burnout

We are beginning 2024 with a matter that extends beyond the confines of pulmonary medicine and really has become something of a crisis in the U.S. healthcare system over the last decades. Organizational psychology expert Dr. Sue Padernacht joins Lungcast to provide an in-depth look into physician burnout—what are its drivers, what factors are exacerbating it, and how the collective medical community can work toward curbing its effect among caregivers.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode Highlights

0:16 Intro
1:44 How to approach stage IV lung cancer, with Dr. David Tom Cooke
4:13 The ALA Lung Health Cohort Research Study, with Dr. Ravi Kalhan
8:42 What is the atopic march, with Dr. Payel Gupta
10:53 Weight loss for asthma care, with Dr. Anne Dixon
15:11 Air Quality Index 101, with Dr. Al Rizzo
18:47 Lung Cancer Age Equity, with Dr. Carolyn Presley
21:45 The emerging treatments for long Covid, with Dr. Julia Moore Vogel
24:28 The future of pulmonary embolism care, with Dr. Parth Rali
28:08 The modern fight against RSV, with Dr. Barbara Taylor
33:26 Detecting unhealthy air exposure, with Dr. Mark Hernandez
36:12 Living while fighting lung cancer, with Christy Fischer
38:51 Outro

Though some subjects are clear favorites, it is nearly impossible to select a single answer to the question, “What was the biggest story in pulmonology this year?” 

Since the American Lung Association (ALA) and HCPLive launched Lungcast in the summer of 2020, the field of respiratory health has evolved in unprecedented fashion. One doesn’t have to look further than the show’s episode library to appreciate the great shifts in the field—brought on by a global pandemic, numerous public health phenomena, and practice-changing innovations in screening, diagnostics, prevention and therapy. From vaccination to late-stage lung cancer care, the world of respiratory health is irrevocably changed from just a short span of 4 years.

To reflect on this year’s spectacular headlines in the field, HCPLive presents the annual recap episode in conjunction with This Year In Medicine, where the Lungcast team reflects on their favorite interview segments of 2023.

Subscribe to Lungcast on YouTube: https://www.youtube.com/@Lungcast

Want more content? Visit us at https://www.hcplive.com/podcasts/lungcast and https://www.lung.org/professional-education/lungcast.

For this episode fully focused on indoor air pollution, we are joined by Professor Mark Hernandez who serves as director of the Aerobiology and Disinfection Lab at the University of Colorado. Listen in to learn about the harmful impact of pollutants such as mold, toxic chemicals and asbestos on respiratory health, particularly in a school setting. Equally important, what can be done to help alleviate these effects?

Episode highlights

0:16 Intro
0:50 Introducing Mark Hernandez, PhD, PE
2:15 The most pressing issues of school air quality
4:12 Advice for school administrators
6:25 The link to pediatric asthma
12:23 Trends in national monitoring
14:16 How COVID-19 changed ventilation priorities
16:29 An equitable, affordable solution
18:34 Signs of unhealthy air exposure
20:53 How clinicians and guardians can get involved
23:47 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Christy Fischer, a miraculous 17-year stage IV lung cancer survivor, connects with us to discuss stress, stigma and significant changes in the treatment landscape. Hear how Christy transformed a daunting diagnosis into hope for others.

This educational and inspirational episode touches upon the raw emotions of what it is like to live (and thrive!) with advanced cancer.

Episode Highlights
0:17 Intro
1:55 Christy's first diagnosis
3:53 Reacting to Stage IV lung cancer
5:28 Initiating treatment
7:18 The lung cancer stigma
9:51 Finding the right doctor
11:16 How lung cancer care changed over 17 years
14:20 Clinical trial participation
16:51 Becoming an advocate
20:33 Advice for physicians diagnosing lung cancer
22:18 How to keep living after diagnosis

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

With cases of Respiratory Syncytial Virus (RSV) on the rise this fall, Dr. Barbara Taylor, professor of infectious diseases at UT Health San Antonio, joins us for this timely episode all about RSV. Importantly, she covers the unprecedented events of the 2022-2023 season that was marred by a ‘tripledemic’ of respiratory diseases.  How do the lessons learned change the preventive approach to better protect against the deadly infection?  

Episode Highlights

0:16 Intro
0:48 The burden of RSV today
2:11 Transmission, presentation and diagnosis of RSV
4:33 Likelihood of an RSV, COVID-19, flu “triple-demic”
7:35 The history of RSV vaccine development
12:09 Risk of RSV mutation and variants
14:19 The new RSV vaccines
20:09 Spacing the RSV vaccine with other seasonal shots
22:14 Age and comorbidities as vaccine criteria
24:30 In vitro immunization
27:39 Nirsevimab and monoclonal antibodies for RSV
29:31 Using the full toolset against RSV
31:50 Yearly COVID-19 vaccine updates?
33:24 A universal flu vaccine?
37:20 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Pulmonary vascular disease expert Dr. Parth Rali at Temple Lung Center helps break down what is known about massive and submassive pulmonary emboli (PE), namely blood clots. This episode provides a comprehensive overview of PE, from the complications of diagnosis to the evolution of therapeutic modalities.

Episode highlights
0:16 Intro
2:34 Defining pulmonary embolism classifications
8:18 The Pulmonary Embolism Severity Index
15:47 The role of D-dimer in diagnosis
17:08 Anticoagulation strategies
22:26 The Pulmonary Embolism Multidisciplinary Response Team
25:38 Long-term outlooks for acute PE
31:38 When to stop anticoagulation
35:27 The future of PE diagnosis and treatment
38:50 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

In this must-listen episode, Dr. Julia Moore Vogel at Scripps Research takes center stage to confer the still-emerging and always-evolving space of long COVID. As patient numbers continue to rise at an alarming rate, she makes a strong case about the critical need to better define the disease, mitigate its impact and, ultimately, break the taboo.

Episode highlights
0:15 Introduction
1:27 Moore Vogel’s background in Long Covid
4:30 Lacking terminology in Long Covid
6:20 Quantifying Long Covid disease
8:38 The mechanism of action: what we know
10:27 Pediatric Long Covid
16:00 Similarities to post-viral syndromes
16:58 Key diagnostic tools
18:37 The current Long Covid treatment landscape
20:57 Influence of SARS-CoV-2 variants and vaccines
22:02 Considering social determinants of health
23:35 Needs for professional and public education
27:00 Final thoughts
28:28 Outro

Want more Lungcast? Visit us at HCPLive.com or Lung.org.

Episode Highlights
0:15 Intro
1:10 Introducing the Lung Health Cohort Research Study
3:49 The enrollment strategy
7:10 Seeking “the cholesterol of lung disease”
11:50 The role of industry support
14:09 Imaging strategies for long-term lung assessment
17:59 Recruitment challenges
23:05 Final thoughts
26:20 Outro

For our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Cohort Research Study. 

Tune in to learn more about their collaborative efforts to help identify biomarkers and lifestyle patterns for more accurate identification of disease processes, ideally at onset. 

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

For this episode focusing on the role of medical oncology, we are joined by Dr. Carolyn Presley, thoracic oncologist and associate professor with tenure at Ohio State University. As a geriatric expert, she provides a poignant point-of-view on the need for a multidisciplinary approach to patient care, as well as advances in treatment that include targeted therapies.

Amid mass poor air quality exposure due to ongoing Canadian wildfires, Lungcast host and ALA Chief Medical Officer Albert Rizzo, MD, explains air quality index (AQI), signs and symptoms of acute and long-term poor air exposure, high-risk patient populations, and the concerning future of particle pollution exposure.

Want more Lungcast? Visit us at HCPLive.com or Lung.org.

Episode Highlights
0:15 Intro
1:23 What is the Air Quality Index?
3:14 Risk factors of poor air quality
4:30 Acute signs and symptoms
6:42 Recommendations for patients with pre-existing conditions
8:09 How long will this last?
10:28 When to resume livelihood
11:12 The long-term impact of air pollution exposure
14:02 Outro

Anne Dixon, MD, Director of Pulmonary and Critical Care Medicine at University of Vermont Medical Center and the first repeat guest in the history of Lungcast, rejoins American Lung Association Chief Medical Officer Albert Rizzo, MD, on the floor at the American Thoracic Society (ATS) 2023 International Conference in Washington, DC, to discuss headline news from the annual meeting and her ongoing work in clinical airway research.

Want more Lungcast? Visit us at HCPLive.com or Lung.org.

Episode Highlights
0:15 Intro
1:00 Obesity burdens in asthma
3:22 Weight loss intervention data at ATS 2023
4:53 ALA grants program
7:00 Airways Clinical Research Network
10:52 Seeking research collaborators
12:46 Merging clinicians, patients and industry in innovative research
13:54 Outro

Just in time for May’s Asthma and Allergy Awareness Month, allergist and immunologist Dr. Payel Gupta of LifeMD.com headlines a conversation about the clinical presentation of asthma and its role in the atopic march. She also details various phenotypes, endotypes and other molecular mechanisms of asthma that can be applied to help guide disease management and treatment decisions.

Episode highlights
0:15 Intro
1:16 Introducing Payel Gupta, MD
2:31 Classifications of asthma
5:35 What is the atopic march?
8:46 The bridge from allergy testing to immunotherapy
12:00 How to initially diagnose asthma
16:02 When to add secondary therapies
18:11 Biologics for uncontrolled asthma
23:20 Real-world use of the SMART therapy guidance
25:40 Assuring asthma treatment adherence
28:35 Addressing asthma care disparities
32:26 The future of asthma research
33:58 Outro

Check out other allergy and/or asthma episodes of Lungcast:

• Poor Indoor Air Quality Exposure and Clinical Risks with Edward Brooks, MD, and Charlene McEvoy, MD
• How PREPARE Data, SMART Recommendations Alter Modern Asthma Strategy
• Fighting Disparities in Pediatric Asthma Care with Dr. LeRoy Graham

Get More From Lungcast

• Lungcast on HCPLive: https://www.hcplive.com/podcasts/lungcast
• Lungcast on American Lung Association: https://www.lung.org/professional-education/lungcast
• Spotify: https://spoti.fi/3YEDxKw
• Apple Podcasts: http://bit.ly/3jCVevq
• YouTube: https://www.youtube.com/@Lungcast/videos

For our 30th episode of Lungcast™, pulmonologist Dr. Ravi Kalhan of Northwestern Medicine joins for a core-level discussion on the modeling of respiratory health and pulmonary mechanisms. 

In addition to sharing how a novel machine learning method may one day soon predict lung disease susceptibility, Dr. Kalhan describes the science behind the American Lung Association Lung Health Cohort Research Study.

David Tom Cooke, MD, Founding Chief of the Division of General Thoracic Surgery at UC Davis, joins the first episode of 2023 to discuss his colleague’s specific role in lung cancer screening and intervention, advances to minimally invasive, robotic and bronchoscopic techniques, and evolving strategies in individualized patient care.

Episode Highlights
0:14 Intro
1:52 Introducing David T. Cooke, MD
3:23 The role of thoracic surgeons in improving lung cancer screening rates
6:22 Shared decision making in thoracic surgery
8:16 Lobar, wedge resection or segmentectomy? Plus, robotic techniques?
12:22 PET/CT scans in the staging process
13:52 The surgeon approach to stage IV lung cancer
16:02 Patient follow-up—improved mortality and longer life expectancy
18:50 Prioritizing surgery and neoadjuvant therapy regimens
20:48 Thoracic surgeon role in palliative care
22:57 What’s on the horizon in the field: robotic surgery
24:17 Outro

Check out other lung cancer episodes of Lungcast:

• Innovations in Interventional Pulmonology with Dr. Carla Lamb 
• Lung Cancer Screening: Trials, Tribulations & Triumphs with Dr. James Mulshine
• Future of Lung Cancer Precision Medicine with Andrea Mazzochi

Get More From Lungcast

• Lungcast on HCPLive: https://www.hcplive.com/podcasts/lungcast
• Lungcast on American Lung Association: https://www.lung.org/professional-education/lungcast
• Spotify: https://spoti.fi/3YEDxKw
• Apple Podcasts: http://bit.ly/3jCVevq
• YouTube: https://www.youtube.com/@Lungcast/videos

Will your New Year’s resolution kick off the journey to quit smoking? In our final Lungcast™ interview of 2022, Bob Levey, former Washington Post columnist and founder of the Super Stoppers Club, and the Lung Association’s national senior director of tobacco programs, Jennifer Folkenroth, come together to review the intricacies of smoking cessation. The lively and informative discussion outlines the path to a smoke-free life, which is often riddled with hurdles and stressors.

0:16 Ernst Wynder, Evarts Graham and the discovery of smoking - lung cancer risk
1:52 Introducing Jennifer Folkenroth and Bob Levey
4:46 Bob Levey and the Super Stoppers Club
11:25 The clinical effect of group cessation
14:00 Why is it hard to quit smoking?
17:45 The value of cessation support systems and social groups
20:03 Navigating patient concerns around cessation treatments
21:54 Combating stigma and social trends
26:35 Resources for aspiring quitters
31:26 Outro

Among many unintended and unexpected effects of sheltering in place during the COVID-19 pandemic is the substantial increase in exposures to indoor allergens and pollutants.

Here, Dr. Edward Brooks at University of Texas at San Antonio and Dr. Charlene McEvoy at University of Minnesota bring a shared expertise on air quality health and research to discuss the resulting health ramifications.

It is an enlightening conversation about the patient populations who are most impacted, plus what can be done to help mitigate the consequences.

Episode highlights
0:16 The history of indoor air environments
2:50 Introducing Edward G. Brooks, MD, and Charlene McEvoy, MD
4:39 The factors of poor indoor air quality
6:25 Ways to improve indoor air quality
8:59 The underlying pathophysiology of pollutants
13:02 Benzene recalls
14:18 High-risk behaviors and disease risks
17:14 Recommendations for exposed patients
21:02 Radon as a lung cancer risk
22:35 Final thoughts
25:42 Outro


For additional news and insights, visit us at HCPLive.com and Lung.org.

Episode highlights
0:16 Alan Turing and the advent of artificial intelligence
2:19 Challenges and needs in IPF
3:13 Introducing Simon Walsh, MD, and Elizabeth Estes
3:58 Evolving IPF diagnostics
7:31 Multidisciplinary teams and centers for IPF
9:52 OSIC’s use of AI and deep learning in IPF
12:36 The inception of OSIC
17:09 Pursuing AI opportunities in pulmonology
21:03 Applying data to clinical research
27:06 Project Opus
33:20 Final thoughts
37:21 Outro

For additional news and insights into respiratory health, be sure to visit us at HCPLive.com and Lung.org.

Modern obstructive sleep apnea presents an under met challenge in pulmonary health. This episode, featuring Dr. Reena Mehra at Cleveland Clinic, delves into the ins and outs of this surprisingly common disease that is practically defined by its hefty symptom burden. Listen in to learn more about sleep apnea’s improved diagnostics and advancing therapies, as well as the role of comorbid conditions.

Episode highlights
0:16 The origin of sleep apnea diagnosis
1:48 Current sleep apnea burden in the US
3:16 Defining obstructive sleep apnea
4:40 The OSA pathophysiology
8:36 Clinical characteristics of OSA
11:16 Role of head and neck anatomy
12:30 Pros and cons of home sleep studies and polysomnography
16:11 Benefit of the Apnea-Hypopnea Index
21:55 The interplay of cardiovascular disease
23:41 The importance of PAP adherence
28:35 Addressing daytime somnolence
32:36 Additional OSA therapy options
35:55 How much weight should patients lose?
36:39 Future diagnosis and treatment
38:25 Outro

For additional news and insights, visit us at HCPLive.com and Lung.org.

In this episode, Dr. Rachel Eddy of the University of British Columbia explores the evolving field of medical imaging technology and the transformative impact of artificial intelligence. While applications of AI have expanded beyond traditional radiology, it delves into cutting-edge techniques like 3D printing and molecular imaging that are redefining diagnostics and treatment planning.

Join us as we focus specifically on the role of AI in chest imaging and uncover how these advancements are improving the future of patient care.

Episode Highlights
0:15 Intro
1:10 The history of medical imaging technology
3:02 Artificial intelligence terminology
8:56 Use of AI to assess asthma airway and mucus changes
13:02 Imaging biomarkers for ILD
16:52 Using AI to observe longterm decline of lung function
21:00 Dysanapsis analysis through CT scans
24:04 Xenon-enhanced MRIs for microstructural lung abnormalities
28:50 How will AI us continue to evolve in pulmonology?
31:58 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Dr. Carla Lamb at Beth Israel Lahey Health joins us to discuss her role in developing early interventional pulmonary training and recommendations, the utility of key diagnostic tools in the subspecialty, evolving roles for lung cancer treatments including bronchial stents, modernized COPD intervention and research, and the future of interventional pulmonary medicine. It is an information-packed interview!

Episode highlights
0:16 Intro 1:49 The history of the interventional pulmonology subspecialty 7:12 The Rescue Lung, Rescue Life Society 10:04 Technological advances to low-dose CT scan accuracy 17:04 Utility of bronchial stents in lung cancer care 21:55 Bronchial thermoplasty in asthmatic patients 26:01 Assessing a COPD patient for volume reduction 32:58 Rheoplasty and targeted lung denervation 35:39 Cryobiopsy in ILD 38:58 The future of interventional pulmonology 42:35 Outro
For additional news and insights, visit us at HCPLive.com and Lung.org.

In recognition of May’s Asthma Awareness Month, this episode highlights our conversation with Dr. Juan Carlos Cardet at University of South Florida and Dr. Elliot Israel at Brigham and Women’s Hospital about the most common respiratory disease in the U.S. It provides a deep dive into the guideline-supported SMART strategy, role of COVID-19 in current asthma risks, and research into the medical and financial impacts of asthma on the U.S. patient population.

Episode highlights
0:16 The Discovery of Asthma 2:12 Introducing Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH 3:20 Defining the SMART asthma strategy 5:46 The slow rollout of SMART 10:19 The strategy and findings of the PREPARE trial 21:41 How to initiate patient-activated reliever-triggered inhaled corticosteroid 25:15 The effect of COVID-19 on real-world asthma trials 27:40 How to lessen the disparities of asthma 31:14 Outro
For additional news and insights, visit us at HCPLive.com and Lung.org.  

The Director of the ILD and Sarcoidosis Program at the Jacksonville College of Medicine joins Dr. Al Rizzo during Sarcoidosis Awareness Month to review the challenges and research surrounding the rare inflammatory disease.

Episode highlights

• 0:16 The history of sarcoidosis
• 1:54 Introducing Mehdi Mirsaeidi, MD, MPH
• 2:54 Understanding inflammatory process in sarcoidosis
• 5:01 How advanced sarcoidosis presents in clinics
• 8:34 Anti-inflammatories for sarcoidosis
• 12:10 The role of lung transplantation
• 14:27 COVID-19 complications among patients
• 16:42 The sarcoidosis specialty care team
• 18:13 Clinical research endeavors
• 19:36 Outro

For additional news and insights, visit us at HCPLive.com and Lung.org.  

For decades, scientists have hypothesized about a future when diseases could be treated with gene editing techniques. The reality is getting closer to fruition! In this fascinating episode, Drs. Eric Kmiec and Natalia Rivera-Torres at ChristianaCare’s Gene Editing Institute share the latest developments in DNA alteration and explain why CRISPR gene editing continues to offer the most promise. 

They also detail how their lab’s pioneering work in squamous cell carcinoma is leading to what will be the first-ever lung cancer patient trial using CRISPR gene editing in a solid tumor.

Learn more about lung cancer screening at HCPLive.com and Lung.org.

Continuing Black History Month, esteemed pediatric pulmonologist Dr. LeRoy Graham of Bridge Atlanta Medical Center drops by to discuss the disparities that continue to exist in childhood asthma. With a 40-plus history helping underserved communities, this easy-to-digest episode hits many high points about improving access to asthma care.

Learn more about lung cancer screening at HCPLive.com and Lung.org.

In recognition of Black History Month, we are joined byinternationally acclaimed sickle cell disease expert Dr. Ify Osunkwo at Atrium Health to address stigma, mistrust and disparities. Born in Nigeria, she shares her unique perspectives on the genesis of this genetic disorder and its inequitable public health impacts. Check out the episode for an interesting overview of a storied disease.

Learn more about lung cancer screening at HCPLive.com and Lung.org.

For the first episode of 2022, we welcome Dr. Gerald Criner at Temple University to summarize key highlights of recent clinical trials and research studies in the COPD field. Additionally, he outlines his work on the development of non-surgical techniques for patients who have advanced COPD. What have been the greatest impacts? Hurdles? Listen and learn.

Learn more about lung cancer screening at HCPLive.com and Lung.org.

Join Dr. Al Rizzo for an end-of-year recap of the best highlights from Lungcast this year, featuring perspectives on COVID-19, asthma, lung cancer, tuberculosis, flu, and more.

With flu season upon us, Dr. Shantanu Agrawal, Chief Health Officer of Anthem Inc., joins us on behalf of their philanthropic arm, Anthem Foundation, to converse about the importance of flu vaccines as a key social driver of health. This episode explores the various vaccination modalities and related public health guidelines, as well as how our joint Fund Off Flu campaign aims to increase influenza knowledge and vaccination rates.

In recognition of Lung Cancer Awareness Month, this episode featuring Dr. James Mulshine at Rush University explains the ins and outs of the improved 2021 lung cancer screening guidelines. While a big step in the right direction, complexities and challenges of equitable access to low-dose CT scans continue to persist, plus the profound impact of the COVID-19 pandemic on screening rates.

Learn more about lung cancer screening at HCPLive.com and Lung.org.

Episode Highlights

0:16 Intro
2:24 Asthma action plans
3:52 Asthma Peak Week
6:28 School nurse’s role
11:05 SMART inhaler strategy for kids
14:25 Addressing vaping among students
20:18 Discussing vaccines with children and parents
24:01 School air quality issues?
27:50 Final thoughts
29:42 Outro

As families jump into the new school year, this episode brings together Chicago-based allergist and immunologist Dr. Juanita Mora and pediatric pulmonologist Dr. S. Christy Sadreameli of Johns Hopkins Hospital to share their tips for making the return to school as smooth as possible in regard to lung health. 

The lively conversation homes in on asthma control and the phenomenon often referred to as ‘peak week,’ along with the prevalence and hazards of vaping and e-cigarettes affecting the school aged population. Grab your pencils and take notes!

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Interstitial lung disease, which prominently includes idiopathic pulmonary fibrosis, is a very broad category of chronic lung conditions with considerable nuance. To help break it down within the context of diagnosis and treatment, Dr. Marilyn Glassberg at University of Arizona joins us to discuss the roles of biomarkers, biopsies and drugs. This episode also sheds light on multidisciplinary clinics and stem cell therapy.

Learn more about ILD and IPF at HCPLive.com and Lung.org.

In this timely episode, we are joined by infectious disease experts Dr. Michael Greenberg of Sanofi Pasteur and Dr. Richard (Rick) Nettles of Johnson & Johnson to discuss respiratory virus immunization. 

It touches upon many hot topics, including the inadvertent health consequences of the pandemic. Additionally, they offer fascinating insight into how unprecedented collaboration and transparency have raised the research bar.

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for the treatment of severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.

See and read more Lungcast recaps and additional interviews at HCPLive.com/sap-partner/american-lung-association.

Listen to Dr. Rizzo's interview with Dr. Anne Dixon on the 2020 asthma management guidelines here.

Visit Lung.org for more resources and expert insights into respiratory disease management.

Episode highlights

• 0:15 Back to school with Asthma Peak Week
• 9:48 Biologics: the emerging severe asthma treatment field
• 11:34 Defining type 2 inflammation and severe asthma
• 15:47 Severe asthma biomarkers
• 21:23 IL-4, IL-13, TSLP: Promising pathways
• 25:49 Severe asthma diagnostic clues
• 28:34 Asthma biologic decision-making
• 35:31 How long-term is a biologic therapy?
• 37:44 The future of asthma-modifying therapy
• 41:09 Understanding asthmatic COVID-19 risk
• 44:57 Outro

Data beget progress. Such is the promise and hope of artificial intelligence, particularly machine learning, to match lung cancer patients with their optimal treatments.

In this episode, Dr. Andrea Mazzocchi, Co-founder and CEO of Known Medicine, dissects the art and the science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic landscape.

The NIH expert joins to highlight the most recent science and understood harms of current e-cigarette devices—and his team's work toward a standardized option for users.

A couple of climate change health experts and advocates join for a timely discussion on the clinical impact of pollution and air quality.

A trio of experts from the Cleveland Clinic join Dr. Rizzo for a talk on lung transplant trends and challenges in the US.

CDC tuberculosis lead Dr. Phillip LoBue joins to discuss the past and present issues of the disease, in time for TB Awareness Day on March 24.

A conversation with an expert virologist and public health advocate on the scientific and societal machinations of COVID-19 vaccination.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

Episode Highlights
0:15 Introduction
2:35 Introducing Janelle Bludorn, MS, PA-C
3:27 Common heat-related illnesses
8:43 How to screen for individual health-related risks
15:27 Respiratory consequences of heat
19:49 The interplay of medicines with heat
26:49 National Weather Service HeatRisk tool
32:58 Behavioral interventions for heat-risk patients
36:27 A FEMA system for heat emergencies?
38:10 Outro

For our July episode, we are visited by Duke University’s Janelle Bludorn, PA-C, MS, for a comprehensive overview of heat-related respiratory illnesses. 

Due to climate change in all regions around the world, extreme heat has become a significant environmental and occupational health hazard with heatstroke classified as a medical emergency. Listen in to better understand the serious risks of exposure to high temperatures.

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Our last episode of 2020 caps advances and ongoing research into the most burdensome chronic respiratory disease in the US.

A discussion with the world-renowned immunologist on COVID-19, Operation Warp Speed, vaccine development, and the future of the pandemic.

The chief of thoracic surgery and surgical director of the Northwestern Medicine Lung Transplant Program discusses his unprecedented procedure during the pandemic, and what the current state of thoracic surgery looks like across diseases.